Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Taro Pharmaceutical Industries Ltd. (TARO)

93.84   1.49 (1.61%) 01-18 16:02
Open: 92.57 Pre. Close: 92.35
High: 95.55 Low: 90
Volume: 61,852 Market Cap: 3662M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 95.693 - 96.079 96.079 - 96.477
Low: 89.091 - 89.475 89.475 - 89.871
Close: 93.19 - 93.878 93.878 - 94.588

Technical analysis

as of: 2019-01-18 4:36:51 PM
Overall:       
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are.
Target: Six months: 111.92     One year: 130.72
Support: Support1: 84.15    Support2: 76.93
Resistance: Resistance1: 95.82    Resistance2: 111.92
Pivot: 90.50
Moving Average: MA(5): 92.17     MA(20): 88.33
MA(100): 96.92     MA(250): 103.29
MACD: MACD(12,26): 0.31     Signal(9): -0.63
Stochastic oscillator: %K(14,3): 77.28     %D(3): 76.05
RSI: RSI(14): 56.65
52-week: High: 121.23  Low: 76.93  Change(%): -10.5
Average Vol(K): 3-Month: 5972  10-Days: 5357

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
TARO has closed below upper band by 26.3%. Bollinger Bands are 21.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-01-15T17:00:00-05:00
Taro Announces Completion of $250 Million Share Repurchase Program

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 39.02
Shares Float (M) 39.02
% Held by Insiders
% Held by Institutions 17.50
Shares Short (K) 487
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est. Current Year 9.490
EPS Est. Next Year 7.990
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 1.580
PEG Ratio -0.95
Profit Margin 44.67
Operating Margin 42.89
Return on Assets (ttm) 9.5
Return on Equity (ttm) 10.4
Qtrly Rev. Growth -6.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 19.40
Operating Cash Flow (M) 342.64
Levered Free Cash Flow (M) 247.67

Stock Valuations

P/E
P/E Growth Ratio
P/BV 59.39
P/S 224916256.00
P/CF 10.69

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date 2018-12-28
Ex-Dividend Date 2018-12-10
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.